Printer Friendly

UPJOHN BOARD ACTS FOLLOWING COOPER'S DEATH

 KALAMAZOO, Mich., April 22 /PRNewswire/ -- The board of directors of The Upjohn Company (NYSE: UPJ) held a special meeting this evening following the death today of Theodore Cooper, chairman and chief executive officer. After adopting a resolution expressing their deepest sympathy to Dr. Cooper's family, the board of directors took the following actions;
 -- Ley S. Smith, president and chief operating officer, was designated to continue serving as acting chief executive officer;
 -- William D. Mulholland was appointed chairman of the executive committee of the board;
 -- William E. LaMothe was appointed chairman of the nominating committee which was directed to review candidates and recommend a permanent chief executive officer.
 The board also reduced the number of directors from twelve to eleven.
 Smith joined Upjohn in Canada as a salesman in 1958 and held a number of sales posts before being appointed general manager of the company's Canadian operations in 1971. He has since served as division vice president for Europe North; group vice president for Western Hemisphere and Canada; corporate vice president and general manager for international; and executive vice president. He became a member of the company board of directors in 1988 and was promoted to vice chairman in 1991. In addition to responsibility for the company's worldwide pharmaceutical business, as president and COO Smith assumed the responsibilities of the CEO in Cooper's absence.
 Mulholland, the former chairman of the board and chief executive officer of the Bank of Montreal, has served as a director at Upjohn since 1977. A former partner of Morgan Stanley and Co., Mulholland first became associated with Upjohn when he assisted with the company's first public offering in 1958. He is currently a director of the Bank of Montreal, Brooks Fashion Stores, Inc., and Canadian Pacific Limited, and is a former director of Rio Tento-Zinc Corporation of London, England, and Standard Life Assurance Company of Edinburgh, Scotland. He is a trustee of Queen's University.
 LaMothe, the former chairman of the board and chief executive officer of Kellogg Company, has served as director at Upjohn since 1986. He is a former director of the Food and Drug Law Institute and Unisys Corporation and is currently a director of Kellogg Company, Kimberly Clark Corporation and Sears Roebuck and Company. LaMothe is also a member of the board and a trustee for the W.K.Kellogg Foundation Trust.
 The Upjohn Company is a worldwide, research-based provider of human health care products, animal health products, agronomic and vegetable seeds and specialty chemicals. Headquartered in Kalamazoo, Mich., the company has been dedicated to improving health and nutrition for more than a century.
 -0- 4/22/93
 /CONTACT: Phillip C. Carra of The Upjohn Company, 616-323-7181/
 (UPJ)


CO: The Upjohn Company ST: Michigan IN: MTC SU: PER

TM -- NY155 -- 9843 04/22/93 21:05 EDT
COPYRIGHT 1993 PR Newswire Association LLC
No portion of this article can be reproduced without the express written permission from the copyright holder.
Copyright 1993 Gale, Cengage Learning. All rights reserved.

Article Details
Printer friendly Cite/link Email Feedback
Publication:PR Newswire
Date:Apr 22, 1993
Words:464
Previous Article:OMC ANNOUNCES NEW VICE PRESIDENTS
Next Article:RON RHODY TO LEAVE BANK OF AMERICA
Topics:


Related Articles
UPJOHN CHAIRMAN TELLS EMPLOYEES OF ILLNESS, FAVORABLE PROGNOSIS
UPJOHN COMPANY CHAIRMAN AND CEO THEODORE COOPER DIES
THE UPJOHN COMPANY SELECTS CHAIRMAN AND CHIEF EXECUTIVE OFFICER
RETIRED UPJOHN CHAIRMAN DIES
UPJOHN PROMOTES THREE EXECUTIVES
UPJOHN ELECTS A.M. GOTTO, JR., TO BOARD
UPJOHN LABS CHIEF TO LEAVE COMPANY JANUARY 2
PHARMACIA & UPJOHN ANNOUNCES U.S. APPOINTMENTS
PHARMACIA & UPJOHN SENIOR VICE PRESIDENT JACK JACKSON NAMED BOARD MEMBER TO THE BOGGY CREEK GANG CAMP
Pharmacia & Upjohn's Zabriskie Resigns; Ekberg to be Interim President

Terms of use | Copyright © 2017 Farlex, Inc. | Feedback | For webmasters